Join Georgia Bio & Bio Alabama on Thursday April 23rd at 10:00am to hear from our national partners BIO & PhRMA and attorneys from Bradley Arant Boult Cummings for a federal policy update. The speakers will discuss recent passed legislation (Supplemental I –Coronavirus Supplemental; Supplemental II – Families First Coronavirus Response Act (HR 6201); Supplemental III – Coronavirus Aid, Relief, and Economic Security (CARES) Act) and the impact on businesses, share insights into the Supplemental IV – “CARES 2.0”, and President Trumps “Buy American” mandates to the medical equipment and biopharmaceutical sector, among other issues.
The format is one hour in length followed by time for Q&A from members. Welcome to submit questions beforehand to Joseph Santoro at firstname.lastname@example.org.
Deputy Vice President
Pharmaceutical Research and Manufacturers of America (PhRMA)
Bart currently serves as a deputy vice president with the Pharmaceutical Research and Manufacturers of America. He began his career in Washington as an Attorney Adviser at the Department of Labor. He later served as legal counsel to four House congressional committees: Foreign Affairs, Science, Judiciary, and the Select Committee on Energy Independence and Global Warming, the latter of which he was also chief of staff. From 2012-2017, he was the chief of staff to Congressman Jim Sensenbrenner. In this role, he staffed several major legislative efforts, including the USA FREEDOM Act—a bill to institute sweeping intelligence reforms—and the Voting Rights Amendment Act—a modernization of the historic civil rights legislation. More recently, he helped spearhead the Judicial Redress Act, a law that facilitated the sharing of law enforcement information between countries by providing citizens of designated countries access to U.S. courts. Bart graduated magna cum laude from Washington and Lee University School of Law.
Senior Director, Federal Government Relations
Biotechnology Industry Organization (BIO)
Jamie Gregorian is Senior Director, Federal Government Relations at the Biotechnology Innovation Organization (BIO). He leads the organization’s lobbying efforts with the majority caucus in the House of Representatives. His work centers on the health portfolio at BIO. At BIO, Jamie has led efforts to pass 21st Century Cures, rein in abusive practices in the 340B program, defeat attempts to weaken intellectual property protections for the industry, and ensure patient access to cutting edge biopharmaceuticals.
Most recently, Jamie helped lead a coalition that got 183 Members of Congress to support expanded sites of service for Part B Medicare patients during the COVID-19 pandemic.
Before joining BIO, Jamie spent five years with the American Academy of Orthopaedic Surgeons (AAOS). Jamie was AAOS’ Senior Manager, Government Relations and Specialties where he worked on a variety of health-related issues and oversaw all advocacy efforts related to judiciary matters, medical research, defense, appropriations, and subspecialty interests. Prior to working at AAOS, Jamie was a contract lobbyist, and before that a longtime Democratic political consultant.
Jamie is a native of Boston, a graduate of James Madison University and George Mason University School of Law, and is licensed to practice law in California. He lives in the District of Columbia with his wife Stephanie and their daughters Lily and Ava.
Governmental Affairs Partner
Bradley Arant Boult Cummings LLP
Ryan Robichaux got his start in politics working as a political analyst in the U.S. Senate and the British Parliament. Prior to law school, Ryan served as a legislative aide for Sen. Jeff Sessions (R-AL), where he specialized in agriculture, judiciary, trade and manufacturing policy. Prior to that, Ryan served as a research assistant for Member of Parliament Nigel Waterson of Eastbourne.
Bradley Arant Boult Cummings
David Stewart got his start in politics working for former United States Senator Jeff Sessions in Washington, D.C. before attending the University of Virginia Law School. After graduating from law school in 2000, David returned home to Birmingham to join Bradley in the firm’s Governmental Affairs Practice Group. He regularly represents clients before the executive and legislative branches in Washington, D.C., and Montgomery, Alabama, and also advises clients on federal and state campaign finance, lobbying and ethics laws.
Being a part of a full-service law firm with a regional and national presence is an important part of David’s practice. Governmental affairs necessarily involves numerous legal and technical disciplines. David routinely draws upon the experience of other professionals in the firm to better serve his clients. Bradley’s geographical reach is also an asset to his clients, as he is able to involve professionals within the firm who have important knowledge and experience dealing with particular government entities, officials and employees.